Want to see ATOS full AI Analyst Report?
Atossa Therapeutics (ATOS) Income Statement
Atossa Therapeutics Income Statement
Last quarter (Q2 2026), Atossa Therapeutics's total revenue was $0.00. In Q2, Atossa Therapeutics's net income was $-8.49M. See Atossa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -17.00K | $ -23.00K | $ -8.00K | $ -23.00K | |
| $ 37.14M | $ 27.62M | $ 31.38M | $ 27.69M | $ 20.52M | |
| Depreciation and Amortization | $ 16.00K | $ 17.00K | $ 23.00K | $ 8.00K | $ 23.00K |
| $ -34.75M | $ -25.49M | $ -30.07M | $ -26.95M | $ -20.58M | |
| $ -37.14M | $ -27.62M | $ -31.38M | $ -27.69M | $ -20.52M | |
| $ 2.37M | $ 2.12M | $ 1.28M | $ 731.00K | $ -85.00K | |
| $ -34.77M | $ -25.50M | $ -30.09M | $ -26.96M | $ -20.61M | |
| $ -34.77M | $ -25.50M | $ -30.09M | $ -26.96M | $ -20.61M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.04 | $ -3.00 | $ -3.60 | $ -3.15 | $ -2.70 |
| Diluted EPS | $ -4.04 | $ -3.00 | $ -3.60 | $ -3.15 | $ -2.70 |
| Weighted Average Shares Outstanding | 8.61M | 8.39M | 8.41M | 8.44M | 7.80M |
| Weighted Average Shares Outstanding (Diluted) | 8.61M | 8.39M | 8.41M | 8.44M | 7.80M |
Currency in USD